Pure Global AI
Colombia INVIMA registration INVIMA 2025RD-0009187

AD-BIO® PRUEBA RÁPIDA DE IGG/IGM DEL VIRUS DE LA HEPATITIS A VHA (SANGRE TOTAL/ SUERO/ PLASMA) (CASSETTE)

HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANYIIIColombia INVIMAExpires May 08, 2030
VerifiedINVIMA · official registry
Device classification
Registered product (Spanish)
AD-BIO® PRUEBA RÁPIDA DE IGG/IGM DEL VIRUS DE LA HEPATITIS A VHA (SANGRE TOTAL/ SUERO/ PLASMA) (CASSETTE)
View exact product-name matches →
Risk class / Clase de riesgo
III
Product group (Spanish)
REACTIVO DIAGNOSTICO
View exact product-group matches →
Registration information
Sanitary registration
INVIMA 2025RD-0009187
Expediente
20302556
Status / Estado
Active
Expiry date
May 08, 2030
Registration holder / Titular
Name
ANNAR DIAGNOSTICA IMPORT S.A.S.
Associated party / Rol
Name
HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY
Role
FABRICANTE
Country
ESTADOS UNIDOS DE AMÉRICA
Manufacturer
HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY
About this record

Access comprehensive regulatory information for AD-BIO® PRUEBA RÁPIDA DE IGG/IGM DEL VIRUS DE LA HEPATITIS A VHA (SANGRE TOTAL/ SUERO/ PLASMA) (CASSETTE) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA sanitary registration INVIMA 2025RD-0009187, held by ANNAR DIAGNOSTICA IMPORT S.A.S. and associated with HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY (FABRICANTE). The registration expires on May 08, 2030.

This page provides complete registration details including product group (REACTIVO DIAGNOSTICO), holder and associated-party information, and regulatory data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.